Table 2.
Treatment Groups | Glutamate (% of baseline) | Lactate/pyruvate ratio | Glycerol (% of baseline) | Nitrite (μM) | DHBA (% of baseline) |
[-]HSP72-N | 100 ± 3 | 9 ± 1 | 102 ± 3 | 14 ± 2 | 100 ± 5 |
[+]HSP72-N | 100 ± 2 | 8 ± 2 | 101 ± 2 | 15 ± 3 | 101 ± 6 |
[-]HSP72-H | 178 ± 9a | 213 ± 14a | 156 ± 7a | 98 ± 9a | 142 ± 7a |
[+]HSP72-H | 108 ± 6b | 25 ± 4b | 21 ± 3b | 26 ± 4b | 109 ± 6b |
Samples were measured 4 h post whole body heating or the equivalent time period for non-heated groups. aCompared with non-heated groups (P < 0.05); bCompared with [-]HSP72-H group (P < 0.05). Data are means ± S.E.M. of 12 mice per group.